alanylglutamine has been researched along with Liver Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blázovics, A; Gero, D; Harsányi, L; Hegedus, V; Kiss, A; Kupcsulik, P; Lotz, G; Módis, K; Ónody, P; Stangl, R; Szabó, C; Szijártó, A; Tamás, J; Tátrai, M | 1 |
1 other study(ies) available for alanylglutamine and Liver Diseases
Article | Year |
---|---|
Reduction of liver ischemia-reperfusion injury via glutamine pretreatment.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Dipeptides; Disease Models, Animal; Glutamine; In Situ Nick-End Labeling; Ischemic Preconditioning; Laser-Doppler Flowmetry; Liver Circulation; Liver Diseases; Male; Microcirculation; Oxidation-Reduction; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2011 |